INS and metabolic dysfunction-associated steatohepatitis: Hepatic steatosis or fatty liver is the first hit in NAFLD pathogenesis, wherein lipotoxicity from the accumulated lipids induces oxidative stress, insulin resistance, inflammation, and fibrosis, leading to the development of non-alcoholic steatohepatitis (NASH).